zidovudine has been researched along with chitosan in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Chacun, H; Couvreur, P; Hillaireau, H; Janin, J; Le Doan, T | 1 |
| Gopal, S; Gupta, P; Mutalik, S; Nayak, UY; Ranjith, AK; Reddy, MS; Udupa, N | 1 |
| Bochot, A; Fattal, E; Giacalone, G; Hillaireau, H | 1 |
| Barbi, Mda S; Barud, Hda S; Carvalho, FC; Gremião, MP; Kiill, CP; Ribeiro, SJ; Santagneli, SH | 1 |
| Capuzzo, A; Dalpiaz, A; Ferraro, L; Fogagnolo, M; Gavini, E; Giunchedi, P; Pavan, B; Rassu, G; Salis, A | 1 |
| Cury, F; Gremião, MP; Pedreiro, LN; Stringhetti, B | 1 |
| Qiu, WY; Wang, YY; Wu, JY; Yan, JK | 1 |
| Joshy, KS; Laly, AP; Nandakumar, K; Sabu, T; Snigdha, S; Susan, MA | 1 |
| Basa, A; Czarnomysy, R; Jacyna, J; Markuszewski, M; Szymanska, E; Wilczewska, AZ; Winnicka, K | 1 |
| Beggiato, S; Dalpiaz, A; Ferraro, L; Fogagnolo, M; Hanuskova, M; Leo, E; Maretti, E; Pavan, B; Sacchetti, F | 1 |
| Boni, FI; Cury, BSF; Ferreira, NN; Gremião, MPD; Pedreiro, LN | 1 |
11 other study(ies) available for zidovudine and chitosan
| Article | Year |
|---|---|
Encapsulation of mono- and oligo-nucleotides into aqueous-core nanocapsules in presence of various water-soluble polymers.
Topics: Cations; Chitosan; Cidofovir; Cyanoacrylates; Cytosine; Dideoxynucleotides; Drug Carriers; Enbucrilate; Materials Testing; Nanocapsules; Nucleotides; Oligonucleotides; Organophosphonates; Permeability; Polyethyleneimine; Polymers; Solubility; Thymine Nucleotides; Water; Zidovudine | 2007 |
Glutaraldehyde cross-linked chitosan microspheres for controlled delivery of zidovudine.
Topics: Anti-HIV Agents; Calorimetry, Differential Scanning; Chitosan; Cross-Linking Reagents; Delayed-Action Preparations; Glutaral; Kinetics; Microspheres; Particle Size; Spectrophotometry, Infrared; Zidovudine | 2009 |
Drug-induced nanocarrier assembly as a strategy for the cellular delivery of nucleotides and nucleotide analogues.
Topics: Adenosine Triphosphate; Animals; Cell Survival; Chitosan; Dideoxynucleotides; Drug Carriers; Drug Delivery Systems; HIV Infections; Macrophages; Mice; Nanoparticles; Nucleotides; Zidovudine | 2013 |
Preparation and Characterization of Chitosan Nanoparticles for Zidovudine Nasal Delivery.
Topics: Administration, Intranasal; Animals; Anti-HIV Agents; Chitosan; Drug Carriers; Mucins; Nanoparticles; Nasal Mucosa; Nuclear Magnetic Resonance, Biomolecular; Permeability; Swine; Zidovudine | 2015 |
Nasal chitosan microparticles target a zidovudine prodrug to brain HIV sanctuaries.
Topics: Administration, Intranasal; Animals; Antiviral Agents; Brain Chemistry; Capsules; Chitosan; Drug Carriers; Male; Prodrugs; Rats, Wistar; Ursodeoxycholic Acid; Zidovudine | 2015 |
Mucoadhesive Nanostructured Polyelectrolyte Complexes as Potential Carrier to Improve Zidovudine Permeability.
Topics: Animals; Chitosan; Drug Carriers; Methylcellulose; Mucins; Nanostructures; Permeability; Zidovudine | 2016 |
Construction and characterization of nanosized curdlan sulfate/chitosan polyelectrolyte complex toward drug release of zidovudine.
Topics: beta-Glucans; Chitosan; Drug Carriers; Drug Liberation; Polyelectrolytes; Zidovudine | 2017 |
Encapsulation of zidovudine in PF-68 coated alginate conjugate nanoparticles for anti-HIV drug delivery.
Topics: Alginates; Amides; Anti-HIV Agents; Chitosan; Drug Carriers; Drug Delivery Systems; Glucuronic Acid; Hexuronic Acids; HIV; HIV Infections; Humans; Nanoparticles; Zidovudine | 2018 |
Could spray-dried microbeads with chitosan glutamate be considered as promising vaginal microbicide carriers? The effect of process variables on the in vitro functional and physicochemical characteristics.
Topics: Administration, Intravaginal; Anti-Infective Agents; Cell Line; Cell Survival; Chitosan; Desiccation; Drug Carriers; Drug Liberation; Female; Glutamates; Humans; Microspheres; Vagina; Zidovudine | 2019 |
Bile salt-coating modulates the macrophage uptake of nanocores constituted by a zidovudine prodrug and enhances its nose-to-brain delivery.
Topics: Administration, Intranasal; Animals; Anti-HIV Agents; Bile Acids and Salts; Brain; Cell Line; Chitosan; Drug Carriers; Excipients; Macrophages; Mice; Nanoparticles; Nasal Mucosa; Nose; Particle Size; Prodrugs; Ursodeoxycholic Acid; Zidovudine | 2019 |
Solid dispersions based on chitosan/hypromellose phthalate blends to modulate pharmaceutical properties of zidovudine.
Topics: Chitosan; Drug Carriers; Humans; Hypromellose Derivatives; Methylcellulose; Polymers; Solubility; Zidovudine | 2022 |